Abraxis BioScience Inc.Los Angeles, CA, United States (NASDAQ (GS): ABII)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Abraxis BioScience Financial Statements

Abraxis BioScience Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Abraxis BioScience Income Statement

  2007 2006 2005
Revenue ($ mil.) 333.7 765.5 518.8
Gross Profit ($ mil.) 299.2 458.0 292.9
Operating Income ($ mil.) (58.1) 0.9 130.3
Total Net Income ($ mil.) (41.6) (46.9) 86.4
Diluted EPS (Net Income) (1.04) (0.30) 1.17
More Abraxis BioScience financial information

Abraxis BioScience Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 77.6 82.1 90.8
Gross Profit ($ mil.) 67.7 73.5 82.5
Operating Income ($ mil.) (88.8) (2.2) (6.6)
Total Net Income ($ mil.) (84.1) 4.3 (5.2)
Diluted EPS (Net Income) (2.11) 0.11 (1.04)
More Abraxis BioScience financial information

Abraxis BioScience Stock Quote & Chart

10/13/08 14:45:00 EST • NASDAQ • 63.08 • Increased by +10.2700 • Increased by +19.4471 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Abraxis BioScience Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 8.10 2.84 1.29
Price/Earnings Ratio -- 12.30 13.49
Price/Book Ratio 2.26 2.24 1.23
Price/Cash Flow Ratio -- 10.70 8.08
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Abraxis BioScience Financial Ratios

Abraxis BioScience Competitive Intelligence

Acusphere Bristol-Myers Squibb Sanofi-Aventis
Annual Sales ($ mil.) 2.7 19,348.0 43,019.0
Employees -- 42,000 99,495
Market Cap ($ mil.) 16.8 41,039.5 --

Competitive Landscape